Medications

Alzheimer's drug trial shows 'evidence of sustained improvement'

Almost four decades ago the University of Aberdeen's Chair in Mental Health (Clinical), Professor Claude Wischik, made a breakthrough in discovering that the neurofibrillary "tangles" associated with Alzheimer's disease were ...

Alzheimer's disease & dementia

Key signaling pathway in immune cells could be new Alzheimer's target

Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer's and some other neurodegenerative diseases, suggests a study by Weill ...

page 4 from 40